Subject: Fw: COVAX Facility – Final Terms and Conditions and Commitment Agreement templates
From: Lia Jabidze <[email-masked]>
To: "[email-masked]" <[email-masked]>
Cc: Amiran Gamkrelidze <[email-masked]>, Ekaterine Adamia <[email-masked]>, Irine Javakhadze <[email-masked]>, Tamta Komakhidze <[email-masked]>
Date: Fri, 28 Aug 2020 05:02:31 +0000

ნინო მოგესალმებით, 
გიგზავნით გავის მიერ მიწოდებულ უახლეს ინფორმაცია. ასევე გაცნობებთ, რომ ჯანდაცვის სამინისტროს ცენტრის მხრიდან გაეგზავნა დეტალური ინფორმაცია კოვაქს ობიექტის შესახებ და გადაწყვეტილების შემთხვევაში, 31 აგვისტოს თანხმობის წერილი  გაიგზავნება გავის სამდივნოში მოთხოვნის შესაბამისად.
პატივისცემით, ლიკა

____________________________
From: COVAX Facility <[email-masked]>
Sent: Friday, August 28, 2020 03:43
To: COVAX Facility
Cc: Tania Paratian; Talha Jalal; Thiago Luchesi; Ronish Darnal (Consultant); Ava Mojtahed; Chioma Nwachukwu; Hamzah Zekrya; Austin Liu (Consultant)
Subject: COVAX Facility – Final Terms and Conditions and Commitment Agreement templates

Your Excellency,
Dear delegates,

Thank you for your ongoing engagement with the COVAX Facility. We are writing to follow up on the correspondence that was sent on August 23 and share with you the final version of the Terms and Conditions and the two Commitment Agreement templates:

  *   Terms and Conditions: This is the final version of the Terms and Conditions that were shared on August 23 and that serve as a basis for the Commitment Agreement. We have added some additional language to clarify the options and timing of payment, so please do review this version.

  *   Two Commitment Agreement templates: These are templates of the legally binding agreement between your Government and Gavi. One template relates to the Committed Purchase Arrangement and one template relates to the Optional Purchase Arrangement. Your Government will only sign the one that you select. A single individualised document will be returned to you following your selection, in the Confirmation of Intent to Participate, of the arrangement (Optional Purchase or Committed Purchase) and the volume of doses you plan to procure through the Facility. We will provide you with your individualised Commitment Agreement after receiving your Confirmation of Intent to Participate on August 31. We will ask you to return the signed Commitment Agreement no later than September 18. The upfront payment and financial guarantee will need to be provided no later than October 9.

We are also sharing a revised version of the COVAX Facility Options Explainer. This document summarises and further articulates the two options for how a participant may choose to join the Facility, also outlined in the Terms and Conditions. This updated version includes additional details and examples to better clarify the distinctions between the two options. This is not a legal document.

We thank you for your ongoing engagement and collaboration in the co-creation of the COVAX Facility and look forward to receiving the signed Confirmation of Intent to Participate. Please do not hesitate to contact us for any questions on the information we have provided.

Please accept the assurances of our highest consideration,

The Office of the COVAX Facility

COVAX Facility Team

Email: [email-masked]<mailto:[email-masked]>

Global Health Campus
Chemin du Pommier 40
1218 Le Grand-Saconnex
Geneva, Switzerland
Tel: + 41 22 909 65 00
Web: http://www.gavi.org<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp-3A__www.gavi.org_%26d%3DCwMFAg%26c%3Daj9Ha5yMZahcf_BRtDCWCQ%26r%3DWZnYwTtWvSAD8LZNFB0XSiVoWCMmzOEj3SljVjmrKE8%26m%3DU22666u2BdlQn4e6cSCEaXntTBQIN9NMg7FQyzoL8d0%26s%3Do9BIz29hoW4SKLR0EH0JpcUw8gpIX5RASSFgXuHJVlc%26e%3D&data=02%7C01%7Ccovax%40gavi.org%7C6204368e84ce4793ed7708d84523f49f%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637335368043929665&sdata=cgvo9IKbPtdU91qYJ7hOrvlqUp36wczYX5v0AKXQaZI%3D&reserved=0>

NOTICE: This email, including any attachments to it, may be confidential and does not create any binding contract on behalf of Gavi or its partners. If this email was sent to you in error, please notify the sender immediately by reply e-mail, and please do not use, distribute, retain, print or copy the e-mail or any attachment.